SCHEMBL1333690

SCHEMBL1333690

COc1cc(F)ccc1OCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
PKM P14618 1/20 0.64
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
FFAR1 O14842 1/20 0.55
FFAR4 Q5NUL3 1/20 0.55
PTGDR2 Q9Y5Y4 5/20 0.54
HDAC1 Q13547 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
GLA P06280 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18045699 0.90 PKM (0.72) POLBSMN1; SMN2PKMMEN1KMT2A
SCHEMBL16149066 0.86 PKM (0.59) POLBSMN1; SMN2PKMMEN1KMT2A
SCHEMBL6783444 0.84 PKM (0.60) POLBSMN1; SMN2PKMMEN1KMT2A
SCHEMBL16741195 0.83 PKM (0.64) POLBSMN1; SMN2PKMMEN1KMT2A
SCHEMBL4384639 0.81 PKM (0.61) POLBSMN1; SMN2PKMFFAR1FFAR4
SCHEMBL25747602 0.81 POLB (0.64) POLBSMN1; SMN2MEN1KMT2AHDAC1
SCHEMBL5275178 0.81 POLB (0.64) POLBSMN1; SMN2MEN1KMT2APTGDR2
SCHEMBL25685569 0.81 POLB (0.64) POLBSMN1; SMN2MEN1KMT2AFFAR1
SCHEMBL4626659 0.81 PKM (0.66) POLBSMN1; SMN2PKMPTGDR2L3MBTL1
SCHEMBL7824774 0.81 PKM (0.66) POLBSMN1; SMN2PKMPTGDR2GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394986-B2 Phenoxiacetic acid derivatives ASTRAZENECA AB (GB) 2013-03-12 US disclosed
US-20110281898-A1 PHENOXIACETIC ACID DERIVATIVES ASTRAZENECA AB 2011-11-17 US disclosed
EP-1660431-B1 PHENOXYACETIC ACID DERIVATIVES ASTRAZENECA AB (SE) 2009-04-01 EP disclosed
EP-1660431-A2 PHENOXYACETIC ACID DERIVATIVES Astrazeneca AB (SE) 2006-05-31 EP disclosed
WO-2005018529-A2 PHENOXIACETIC ACID DERIVATIVES ASTRAZENECA AB (SE) 2005-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281898-A1 PHENOXIACETIC ACID DERIVATIVES HIF1A, HPD, HIF1AN POLB 3168/4885SMN1; SMN2 2874/4885PKM 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.